M. Visca

Severe Acute Respiratory Syndrome Coronavirus Elicits a Weak Interferon Response Compared to Traditional Interferon-Inducing Viruses

C. Scagnolari, G. Antonelli, C. Selvaggi, 2008, Intervirology.

Anti-HBV treatment induces novel reverse transcriptase mutations with reflective effect on HBV S antigen.

B. Berkhout, F. Ceccherini‐Silberstein, M. Andreoni, 2013, The Journal of infection.

Role of hepatitis B virus genetic barrier in drug-resistance and immune-escape development.

F. Ceccherini‐Silberstein, H. Fleury, F. Mazzotta, 2011, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

The profile of mutational clusters associated with lamivudine resistance can be constrained by HBV genotypes.

F. Ceccherini‐Silberstein, C. Perno, A. Spanò, 2009, Journal of hepatology.

Lamivudine-resistance mutations can be selected even at very low levels of hepatitis B viraemia.

F. Ceccherini‐Silberstein, A. Ursitti, C. Perno, 2010, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Specific mutations in the C-terminus domain of HBV surface antigen significantly correlate with low level of serum HBV-DNA in patients with chronic HBV infection.

B. Berkhout, H. Fleury, M. Andreoni, 2015, The Journal of infection.

Snapshot on drug‐resistance rate and profiles in patients with chronic hepatitis B receiving nucleos(t)ide analogues in clinical practice

C. Perno, M. Andreoni, M. Angelico, 2013, Journal of medical virology.

Novel HBsAg markers tightly correlate with occult HBV infection and strongly affect HBsAg detection.

Valentina Svicher, Jens Verheyen, Valeria Micheli, 2012, Antiviral research.